Prime Medicine
Christian Byrd's work experience includes various roles in the pharmaceutical industry. From January 2019 to June 2019, they worked as an Analytical Chemistry Co-op at Tetraphase Pharmaceuticals. Following this, from January 2020 to June 2020, they worked as a Formulations Co-op at Concert Pharmaceuticals, Inc. Finally, in May 2022, they joined Prime Medicine, Inc. as an LNP Formulations Co-op, and later advanced to the role of Associate Engineer II in December 2022.
Christian Byrd completed their undergraduate education at Northeastern University from 2017 to 2021, where they earned a Bachelor of Science Degree in Chemical Engineering. Christian then continued their studies at the same institution from 2021 to 2022, obtaining a Master of Science - MS in Chemical Engineering.
This person is not in any offices
Prime Medicine
4 followers
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.